ANIX
Price
$3.40
Change
-$0.04 (-1.16%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
110.48M
52 days until earnings call
RYTM
Price
$88.49
Change
-$0.71 (-0.80%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
5.85B
14 days until earnings call
Interact to see
Advertisement

ANIX vs RYTM

Header iconANIX vs RYTM Comparison
Open Charts ANIX vs RYTMBanner chart's image
Anixa Biosciences
Price$3.40
Change-$0.04 (-1.16%)
Volume$1.4K
Capitalization110.48M
Rhythm Pharmaceuticals
Price$88.49
Change-$0.71 (-0.80%)
Volume$11.52K
Capitalization5.85B
ANIX vs RYTM Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. RYTM commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and RYTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ANIX: $3.44 vs. RYTM: $88.63)
Brand notoriety: ANIX and RYTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 53% vs. RYTM: 87%
Market capitalization -- ANIX: $110.48M vs. RYTM: $5.85B
ANIX [@Biotechnology] is valued at $110.48M. RYTM’s [@Biotechnology] market capitalization is $5.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileRYTM’s FA Score has 1 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • RYTM’s FA Score: 1 green, 4 red.
According to our system of comparison, RYTM is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 3 TA indicator(s) are bullish while RYTM’s TA Score has 6 bullish TA indicator(s).

  • ANIX’s TA Score: 3 bullish, 5 bearish.
  • RYTM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RYTM is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а +9.55% price change this week, while RYTM (@Biotechnology) price change was -0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.19%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +33.92%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 12, 2025.

RYTM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($5.85B) has a higher market cap than ANIX($110M). RYTM YTD gains are higher at: 58.324 vs. ANIX (47.845). ANIX has higher annual earnings (EBITDA): -13.11M vs. RYTM (-145.8M). RYTM has more cash in the bank: 314M vs. ANIX (15.6M). ANIX has less debt than RYTM: ANIX (221K) vs RYTM (4.06M). RYTM has higher revenues than ANIX: RYTM (137M) vs ANIX (0).
ANIXRYTMANIX / RYTM
Capitalization110M5.85B2%
EBITDA-13.11M-145.8M9%
Gain YTD47.84558.32482%
P/E RatioN/AN/A-
Revenue0137M-
Total Cash15.6M314M5%
Total Debt221K4.06M5%
FUNDAMENTALS RATINGS
ANIX vs RYTM: Fundamental Ratings
ANIX
RYTM
OUTLOOK RATING
1..100
624
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
8023
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4436
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIX's Valuation (74) in the Computer Peripherals industry is in the same range as RYTM (98) in the Biotechnology industry. This means that ANIX’s stock grew similarly to RYTM’s over the last 12 months.

RYTM's Profit vs Risk Rating (23) in the Biotechnology industry is somewhat better than the same rating for ANIX (80) in the Computer Peripherals industry. This means that RYTM’s stock grew somewhat faster than ANIX’s over the last 12 months.

ANIX's SMR Rating (97) in the Computer Peripherals industry is in the same range as RYTM (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to RYTM’s over the last 12 months.

RYTM's Price Growth Rating (36) in the Biotechnology industry is in the same range as ANIX (44) in the Computer Peripherals industry. This means that RYTM’s stock grew similarly to ANIX’s over the last 12 months.

RYTM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that RYTM’s stock grew similarly to ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXRYTM
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 1 day ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FESGX73.260.25
+0.34%
First Eagle Global C
FAKDX12.06N/A
N/A
Kempner Multi-Cap Deep Value Investor
MREGX15.32N/A
N/A
BlackRock Unconstrained Equity R
MNOZX36.25N/A
N/A
Manning & Napier Overseas Series Z
JCPRX23.10N/A
N/A
JPMorgan US Large Cap Core Plus R5

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with LGND. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-0.29%
LGND - ANIX
34%
Loosely correlated
+1.45%
KYMR - ANIX
33%
Poorly correlated
-2.25%
VERA - ANIX
32%
Poorly correlated
-1.13%
FDMT - ANIX
31%
Poorly correlated
+0.47%
GLUE - ANIX
31%
Poorly correlated
-1.85%
More

RYTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with CRNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
-0.64%
CRNX - RYTM
46%
Loosely correlated
-0.51%
VRNA - RYTM
45%
Loosely correlated
N/A
IDYA - RYTM
43%
Loosely correlated
+1.02%
RVMD - RYTM
43%
Loosely correlated
+0.31%
DNLI - RYTM
42%
Loosely correlated
-1.21%
More